Copyright
©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Sep 14, 2009; 15(34): 4278-4283
Published online Sep 14, 2009. doi: 10.3748/wjg.15.4278
Published online Sep 14, 2009. doi: 10.3748/wjg.15.4278
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study
Francois Ghiringhelli, Bruno Chauffert, Sylvain Ladoire, Department of Medical Oncology, Georges-Francois Leclerc Cancer Center, Dijon 21000, France
Boris Guiu, Department of Radiology, Georges-Francois Leclerc Cancer Center, Dijon 21000, France
Author contributions: Ghiringhelli F and Chauffert B designed the research; Ghiringhelli F, Guiu B and Ladoire S performed the research and analyzed the data; Ghiringhelli F, Guiu B, Chauffert B and Ladoire S wrote the article.
Supported by A Grant From Association Pour la Recherche Contre le Cancer, Ligue Régionale De Bourgogne Contre le Cancer, INSERM, Fondation de France and GERTI (Groupe d’Etude en Thérapeutique Inovante) Study number GERTI-P001
Correspondence to: Francois Ghiringhelli, MD, PhD, Department of Medical Oncology, Georges-Francois Leclerc Cancer Center, INSERM avenir 866, 1 rue du professeur Marion, Dijon 21000, France. fghiringhelli@dijon.fnclcc.fr
Telephone: +33-3-80393353 Fax: +33-3-80393434
Received: June 1, 2009
Revised: July 16, 2009
Accepted: July 23, 2009
Published online: September 14, 2009
Revised: July 16, 2009
Accepted: July 23, 2009
Published online: September 14, 2009
Core Tip